Patent details

EP3733650 Title: METHOD FOR PREPARING ELAGOLIX INTERMEDIATE AND COMPOSITION THEREOF

Basic Information

Publication number:
EP3733650
PCT Application Number:
CN2018123468
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP188956882
PCT Publication Number:
WO2019128983
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHOD FOR PREPARING ELAGOLIX INTERMEDIATE AND COMPOSITION THEREOF
French Title of Invention:
PROCÉDÉ DE PRÉPARATION D'UN INTERMÉDIAIRE D'ÉLAGOLIX ET COMPOSITION ASSOCIÉE
German Title of Invention:
VERFAHREN ZUR HERSTELLUNG EINES ELAGOLIX-ZWISCHENPRODUKTS UND ZUSAMMENSETZUNG DAVON
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
27/09/2024
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
24/10/2024
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
28/08/2024
Unitary Effect Registration Date:
24/10/2024
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
25/12/2018
Grant date:
28/08/2024
EP Publication Date:
04/11/2020
PCT Publication Date:
04/07/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/08/2024
EP B1 Publication Date:
28/08/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
25/12/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/08/2024
 
 

Name:
Shanghai Syncores Technologies Inc. Ltd.
Address:
538 Cailun Road Zhangjiang Hi-Tech Park Pudong New District, Shanghai 201203, China (CN)

Name:
Zhejiang Huahai Pharmaceutical Co., Ltd.
Address:
Xunqiao, Linhai, Taizhou, Zhejiang 317024, China (CN)

Inventor

1

Name:
HE, Kang
Address:
China (CN)

2

Name:
GUO, Xiaowen
Address:
China (CN)

3

Name:
HUANG, Luning
Address:
China (CN)

4

Name:
SU, Hu
Address:
China (CN)

5

Name:
LIANG, Yukun
Address:
China (CN)

6

Name:
GU, Hong
Address:
China (CN)

7

Name:
SHI, Kaiqiang
Address:
China (CN)

8

Name:
YANG, Jintao
Address:
China (CN)

9

Name:
CHEN, Xi
Address:
China (CN)

10

Name:
TAO, Anping
Address:
China (CN)

11

Name:
AN, Jianguo
Address:
China (CN)

Priority

Priority Number:
201711445252
Priority Date:
27/12/2017
Priority Country:
China (CN)

Classification

IPC classification:
C07D 239/54;

Publication

European Patent Bulletin

1

Issue number:
202435
Publication date:
28/08/2024
Description:
Grant (B1)

2

Issue number:
202445
Publication date:
06/11/2024
Description:
Unitary Effect Request Receipt

3

Issue number:
202448
Publication date:
27/11/2024
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages